Abstract:Understanding the complex interactions between virus and host that drive new strain evolution is key to predicting the emergence potential of variants and informing vaccine development. Under our hypothesis, future dominant human norovirus GII.4 variants with critical antigenic properties that allow them to spread are currently circulating undetected, having diverged years earlier. Through large-scale sequencing of GII.4 surveillance samples, we identified two variants with extensive divergence within domains that mediate neutralizing antibody binding. Subsequent serological characterization of these strains using temporally resolved adult and child sera suggests that neither candidate could spread globally in adults with multiple GII.4 exposures, yet young children with minimal GII.4 exposure appear susceptible. Antigenic cartography of surveillance and outbreak sera indicates that continued population exposure to GII.4 Sydney 2012 and antigenically related variants over a 6-year period resulted in a broadening of immunity to heterogeneous GII.4 variants, including those identified here. We show that the strongest antibody responses in adults exposed to GII.4 Sydney 2012 are directed to previously circulating GII.4 viruses. Our data suggest that the broadening of antibody responses compromises establishment of strong GII.4 Sydney 2012 immunity, thereby allowing the continued persistence of GII.4 Sydney 2012 and modulating the cycle of norovirus GII.4 variant replacement. Our results indicate a cycle of norovirus GII.4 variant replacement dependent upon population immunity. Young children are susceptible to divergent variants; therefore, emergence of these strains worldwide is driven proximally by changes in adult serological immunity and distally by viral evolution that confers fitness in the context of immunity. IMPORTANCE In our model, preepidemic human norovirus variants harbor genetic diversification that translates into novel antigenic features without compromising viral fitness. Through surveillance, we identified two viruses fitting this profile, forming long branches on a phylogenetic tree. Neither evades current adult immunity, yet young children are likely susceptible. By comparing serological responses, we demonstrate that population immunity varies by age/exposure, impacting predicted susceptibility to variants. Repeat exposure to antigenically similar variants broadens antibody responses, providing immunological coverage of diverse variants but compromising response to the infecting variant, allowing continued circulation. These data indicate norovirus GII.4 variant replacement is driven distally by virus evolution and proximally by immunity in adults.

Human norovirus transmission and evolution in a changing world

Immune Imprinting Drives Human Norovirus Potential for Global Spread

Capturing norovirus transmission

Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity

Viral intra-host evolution in immunocompetent children contributes to human norovirus diversification at the global scale

Emergence of norovirus strains: A tale of two genes

Phylogenetic Investigation of Norovirus Transmission between Humans and Animals

Intra- and Inter-host Evolution of Human Norovirus in Healthy Adults

[Noroviruses--tactic of spread]

Norovirus: Facts and Reflections from Past, Present, and Future

Recent advances in human norovirus research and implications for candidate vaccines

Molecular and Genetics-Based Systems for Tracing the Evolution and Exploring the Mechanisms of Human Norovirus Infections

What Is the Reservoir of Emergent Human Norovirus Strains?

The variation of antigenic and histo-blood group binding sites synergistically drive the evolution among chronologically emerging GII.4 noroviruses

Structural Adaptations of Norovirus GII.17/13/21 Lineage Through Two Distinct Evolutionary Paths

Evolution of the interactions between GII.4 noroviruses and histo-blood group antigens: Insights from experimental and computational studies

Patterns of the within-host evolution of human norovirus in immunocompromised individuals and implications for treatment

Animals as Reservoir for Human Norovirus

Noroviruses: Evolutionary Dynamics, Epidemiology, Pathogenesis, and Vaccine Advances—A Comprehensive Review

Genetic Susceptibility to Human Norovirus Infection: An Update

Molecular Evolution of Human Norovirus GII.2 Clusters